Syntec Optics (NASDAQ: OPTX) has received a new $4.6 million purchase order for the continued production of advanced laser-based blood testing cartridges and optical reader subsystems used in medical diagnostic equipment deployed across hospitals and clinics worldwide.
The company announced Tuesday that the order supports the manufacturing of precision-engineered components used in point-of-care diagnostic systems designed to provide rapid analysis of critical patient health indicators.
According to Syntec, the products are utilized in blood-testing instruments that measure key biomarkers, including hemoglobin levels, electrolytes, and metabolic indicators. These systems are widely used in hospitals, trauma centers, intensive care units (ICUs), neonatal intensive care units (NICUs), operating rooms, and emergency departments where rapid diagnostic results are essential for patient care.
Company executives said the order highlights the continued strength of Syntec’s biomedical technology business, which complements its growing presence in defense and space-related manufacturing markets.
“Recurring demand for our biomedical product lines continues to provide a stable foundation for the business while we expand our capabilities in high-growth sectors such as defense and space technology,” the company said.
The optical components manufactured by Syntec are designed to support point-of-care testing environments where healthcare providers require fast and accurate diagnostic information. In critical care settings, blood gas and metabolic tests are often performed multiple times per day to monitor patient conditions and guide treatment decisions.
The company noted that advanced diagnostic systems equipped with its optical technologies can deliver important clinical measurements within approximately one minute, significantly reducing waiting times compared with traditional laboratory testing processes.
Syntec also highlighted the role its manufacturing capabilities played during the COVID-19 pandemic, when demand for rapid diagnostic technologies increased significantly. The company said its optical solutions helped support bedside testing applications used in respiratory care and emergency medical environments.
As part of the newly awarded contract, Syntec has already delivered approximately half a million dollars’ worth of products and expects to complete full order fulfillment by the third quarter of 2026.
The order underscores the growing importance of precision optics in modern healthcare, where hospitals increasingly rely on rapid diagnostic technologies to improve patient outcomes and operational efficiency.
Headquartered in Rochester, New York, Syntec Optics develops and manufactures advanced optical systems and components serving customers in biomedical technology, defense, aerospace, and industrial markets. The company continues to expand its portfolio of high-precision optical solutions across multiple industries where accuracy and reliability are critical.